Why Johnson & Johnson stock is slipping today after JNJ’s 2026 forecast

Johnson & Johnson shares slipped 0.2% to $218.21 in after-hours trading on Tuesday, the session after the 4 p.m. close, as investors positioned for the drugmaker’s quarterly results due on Wednesday. The stock traded between $214.70 and $218.70 during the day.

Johnson & Johnson shares slipped roughly 0.4% to $217.68 on Tuesday, recovering slightly after an initial drop as investors held back ahead of the upcoming quarterly earnings release.

Johnson & Johnson shares ended Friday down 0.4%, closing at $218.66. Investors are cautious ahead of the holiday-shortened week and the company's earnings report due Wednesday.

Johnson & Johnson shares edged down 0.41% Friday, finishing at $218.66, as U.S. healthcare stocks struggled. Pfizer slipped 0.93%, while Merck tumbled 1.93% during the session.

Johnson & Johnson shares held steady in after-hours trading Friday, following a 0.41% drop that closed the day at $218.66. The after-hours session typically sees lighter volume.

Johnson & Johnson shares climbed about 1.9%, closing at $213.65 on Tuesday, and stayed near that level in after-hours trading after Delaware’s highest court pared down part of a $1 billion damages award related to its Auris Health acquisition. The Delaware Supreme Court ordered a recalculation that could shave a few hundred million dollars, including interest, off the total. This dispute traces back to J&J’s 2019 purchase of surgical-robot maker Auris and the earnout payments tied to performance milestones owed to former shareholders. “We are pleased that the court reversed the trial court’s improper substitution,” J&J said.